Literature DB >> 5332981

A factor in the serum of patients with persisting infection that inhibits the bactericidal activity of normal serum against the organism that is causing the infection.

B A Waisbren, I Brown.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5332981

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  20 in total

1.  Complement-mediated immune mechanisms in renal infection. II. Effect of decomplementation.

Authors:  T E Miller; S Phillips; I J Simpson
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

2.  [Treatment with antibiotic agents with special reference to their relation to otorhinolaryngology].

Authors:  E von Wasielewski; E Schütze
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1967

3.  [Serum resistance and "nephropathogenicity" of antigenetically defined E. coli strains. II. Behavior of different serum resistant bacilli in vitro].

Authors:  W Henkel
Journal:  Z Med Mikrobiol Immunol       Date:  1971

4.  Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.

Authors:  K A Joiner; R Scales; K A Warren; M M Frank; P A Rice
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

Review 5.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

6.  The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity.

Authors:  S Shaw; A L Smith; P Anderson; D H Smith
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

7.  Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces.

Authors:  R M Hamadeh; G A Jarvis; U Galili; R E Mandrell; P Zhou; J M Griffiss
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

8.  Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection.

Authors:  R M Guttman; B A Waisbren
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

9.  The bactericidal activity of sera of healthy neonates and of newborns with hyperbilirubinaemia to Escherichia coli.

Authors:  I Miler; J Vondrácek; L Hromádková
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

10.  Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  M J Thomassen; C A Demko
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.